Lento Bio, Inc.
PrivateLast Round
Seed
May 30, 2023
Total Funding Raised
$3.58M
Company Overview
Lento Bio, Inc. is a biotechnology company developing small-molecule eyedrops to treat presbyopia by restoring ocular lens flexibility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lento Bio, Inc. Comparables
Compare Lento Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glaukos Corporation | 74% | |
| Novartis | 73% | |
| Orasis Pharmaceuticals | 70% | |
Lento Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2023 | ||||
| Pre Seed | Sep 6, 2022 |
Lento Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Excell Partners | Seed |
| Richmond View Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2023
$2.9M round led by Excell Partners and Ichor Life Sciences
- Sep 6, 2022
$680K round led by Ichor Life Sciences.
Lento Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lento Bio, Inc.'s valuation, stock price, and market status.